Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative

Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among patients with type 2 diabetes. This observational retrospective study investigated whether diabetic dyslipidemia-that is, high triglyceride (TG...

Full description

Saved in:
Bibliographic Details
Published inDiabetes care Vol. 39; no. 12; pp. 2278 - 2287
Main Authors Russo, Giuseppina T., De Cosmo, Salvatore, Viazzi, Francesca, Pacilli, Antonio, Ceriello, Antonio, Genovese, Stefano, Guida, Pietro, Giorda, Carlo, Cucinotta, Domenico, Pontremoli, Roberto, Fioretto, Paola
Format Journal Article
LanguageEnglish
Published United States American Diabetes Association 01.12.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among patients with type 2 diabetes. This observational retrospective study investigated whether diabetic dyslipidemia-that is, high triglyceride (TG) and/or low HDL cholesterol (HDL-C) levels-contributes to this high residual risk for DKD. Among a total of 47,177 patients attending Italian diabetes centers, 15,362 patients with a baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m , normoalbuminuria, and LDL-C ≤130 mg/dL completing a 4-year follow-up were analyzed. The primary outcome was the incidence of DKD, defined as either low eGFR (<60 mL/min/1.73 m ) or an eGFR reduction >30% and/or albuminuria. Overall, 12.8% developed low eGFR, 7.6% an eGFR reduction >30%, 23.2% albuminuria, and 4% albuminuria and either eGFR <60 mL/min/1.73 m or an eGFR reduction >30%. TG ≥150 mg/dL increased the risk of low eGFR by 26%, of an eGFR reduction >30% by 29%, of albuminuria by 19%, and of developing one abnormality by 35%. HDL-C <40 mg/dL in men and <50 mg/dL in women were associated with a 27% higher risk of low eGFR and a 28% risk of an eGFR reduction >30%, with a 24% higher risk of developing albuminuria and a 44% risk of developing one abnormality. These associations remained significant when TG and HDL-C concentrations were examined as continuous variables and were only attenuated by multivariate adjustment for numerous confounders. In a large population of outpatients with diabetes, low HDL-C and high TG levels were independent risk factors for the development of DKD over 4 years.
AbstractList Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among patients with type 2 diabetes. This observational retrospective study investigated whether diabetic dyslipidemia-that is, high triglyceride (TG) and/or low HDL cholesterol (HDL-C) levels-contributes to this high residual risk for DKD. Among a total of 47,177 patients attending Italian diabetes centers, 15,362 patients with a baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m , normoalbuminuria, and LDL-C ≤130 mg/dL completing a 4-year follow-up were analyzed. The primary outcome was the incidence of DKD, defined as either low eGFR (<60 mL/min/1.73 m ) or an eGFR reduction >30% and/or albuminuria. Overall, 12.8% developed low eGFR, 7.6% an eGFR reduction >30%, 23.2% albuminuria, and 4% albuminuria and either eGFR <60 mL/min/1.73 m or an eGFR reduction >30%. TG ≥150 mg/dL increased the risk of low eGFR by 26%, of an eGFR reduction >30% by 29%, of albuminuria by 19%, and of developing one abnormality by 35%. HDL-C <40 mg/dL in men and <50 mg/dL in women were associated with a 27% higher risk of low eGFR and a 28% risk of an eGFR reduction >30%, with a 24% higher risk of developing albuminuria and a 44% risk of developing one abnormality. These associations remained significant when TG and HDL-C concentrations were examined as continuous variables and were only attenuated by multivariate adjustment for numerous confounders. In a large population of outpatients with diabetes, low HDL-C and high TG levels were independent risk factors for the development of DKD over 4 years.
OBJECTIVE Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among patients with type 2 diabetes. This observational retrospective study investigated whether diabetic dyslipidemia -- that is, high triglyceride (TG) and/or low HDL cholesterol (HDL-C) levels -- contributes to this high residual risk for DKD. RESEARCH DESIGN AND METHODS Among a total of 47,177 patients attending Italian diabetes centers, 15,362 patients with a baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2, normoalbuminuria, and LDL-C ≤130 mg/dL completing a 4-year follow-up were analyzed. The primary outcome was the incidence of DKD, defined as either low eGFR (<60 mL/min/1.73 m2) or an eGFR reduction >30% and/or albuminuria. RESULTS Overall, 12.8% developed low eGFR, 7.6% an eGFR reduction >30%, 23.2% albuminuria, and 4% albuminuria and either eGFR <60 mL/min/1.73 m2 or an eGFR reduction >30%. TG ≥150 mg/dL increased the risk of low eGFR by 26%, of an eGFR reduction >30% by 29%, of albuminuria by 19%, and of developing one abnormality by 35%. HDL-C <40 mg/dL in men and <50 mg/dL in women were associated with a 27% higher risk of low eGFR and a 28% risk of an eGFR reduction >30%, with a 24% higher risk of developing albuminuria and a 44% risk of developing one abnormality. These associations remained significant when TG and HDL-C concentrations were examined as continuous variables and were only attenuated by multivariate adjustment for numerous confounders. CONCLUSIONS In a large population of outpatients with diabetes, low HDL-C and high TG levels were independent risk factors for the development of DKD over 4 years.
Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among patients with type 2 diabetes. This observational retrospective study investigated whether diabetic dyslipidemia-that is, high triglyceride (TG) and/or low HDL cholesterol (HDL-C) levels-contributes to this high residual risk for DKD.OBJECTIVEDespite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among patients with type 2 diabetes. This observational retrospective study investigated whether diabetic dyslipidemia-that is, high triglyceride (TG) and/or low HDL cholesterol (HDL-C) levels-contributes to this high residual risk for DKD.Among a total of 47,177 patients attending Italian diabetes centers, 15,362 patients with a baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2, normoalbuminuria, and LDL-C ≤130 mg/dL completing a 4-year follow-up were analyzed. The primary outcome was the incidence of DKD, defined as either low eGFR (<60 mL/min/1.73 m2) or an eGFR reduction >30% and/or albuminuria.RESEARCH DESIGN AND METHODSAmong a total of 47,177 patients attending Italian diabetes centers, 15,362 patients with a baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2, normoalbuminuria, and LDL-C ≤130 mg/dL completing a 4-year follow-up were analyzed. The primary outcome was the incidence of DKD, defined as either low eGFR (<60 mL/min/1.73 m2) or an eGFR reduction >30% and/or albuminuria.Overall, 12.8% developed low eGFR, 7.6% an eGFR reduction >30%, 23.2% albuminuria, and 4% albuminuria and either eGFR <60 mL/min/1.73 m2 or an eGFR reduction >30%. TG ≥150 mg/dL increased the risk of low eGFR by 26%, of an eGFR reduction >30% by 29%, of albuminuria by 19%, and of developing one abnormality by 35%. HDL-C <40 mg/dL in men and <50 mg/dL in women were associated with a 27% higher risk of low eGFR and a 28% risk of an eGFR reduction >30%, with a 24% higher risk of developing albuminuria and a 44% risk of developing one abnormality. These associations remained significant when TG and HDL-C concentrations were examined as continuous variables and were only attenuated by multivariate adjustment for numerous confounders.RESULTSOverall, 12.8% developed low eGFR, 7.6% an eGFR reduction >30%, 23.2% albuminuria, and 4% albuminuria and either eGFR <60 mL/min/1.73 m2 or an eGFR reduction >30%. TG ≥150 mg/dL increased the risk of low eGFR by 26%, of an eGFR reduction >30% by 29%, of albuminuria by 19%, and of developing one abnormality by 35%. HDL-C <40 mg/dL in men and <50 mg/dL in women were associated with a 27% higher risk of low eGFR and a 28% risk of an eGFR reduction >30%, with a 24% higher risk of developing albuminuria and a 44% risk of developing one abnormality. These associations remained significant when TG and HDL-C concentrations were examined as continuous variables and were only attenuated by multivariate adjustment for numerous confounders.In a large population of outpatients with diabetes, low HDL-C and high TG levels were independent risk factors for the development of DKD over 4 years.CONCLUSIONSIn a large population of outpatients with diabetes, low HDL-C and high TG levels were independent risk factors for the development of DKD over 4 years.
Author Viazzi, Francesca
Cucinotta, Domenico
Russo, Giuseppina T.
Fioretto, Paola
Pacilli, Antonio
Genovese, Stefano
Guida, Pietro
Ceriello, Antonio
Giorda, Carlo
De Cosmo, Salvatore
Pontremoli, Roberto
Author_xml – sequence: 1
  givenname: Giuseppina T.
  surname: Russo
  fullname: Russo, Giuseppina T.
  organization: Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
– sequence: 2
  givenname: Salvatore
  surname: De Cosmo
  fullname: De Cosmo, Salvatore
  organization: Department of Medical Sciences, Scientific Institute “Casa Sollievo della Sofferenza,” San Giovanni Rotondo, Italy
– sequence: 3
  givenname: Francesca
  surname: Viazzi
  fullname: Viazzi, Francesca
  organization: Università degli Studi and IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genova, Italy
– sequence: 4
  givenname: Antonio
  surname: Pacilli
  fullname: Pacilli, Antonio
  organization: Department of Medical Sciences, Scientific Institute “Casa Sollievo della Sofferenza,” San Giovanni Rotondo, Italy
– sequence: 5
  givenname: Antonio
  surname: Ceriello
  fullname: Ceriello, Antonio
  organization: Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain, Department of Cardiovascular and Metabolic Diseases, IRCCS Gruppo Multimedica, Sesto San Giovanni, Italy
– sequence: 6
  givenname: Stefano
  surname: Genovese
  fullname: Genovese, Stefano
  organization: Department of Cardiovascular and Metabolic Diseases, IRCCS Gruppo Multimedica, Sesto San Giovanni, Italy
– sequence: 7
  givenname: Pietro
  surname: Guida
  fullname: Guida, Pietro
  organization: Associazione Medici Diabetologi, Rome, Italy
– sequence: 8
  givenname: Carlo
  surname: Giorda
  fullname: Giorda, Carlo
  organization: Diabetes and Metabolism Unit, ASL Turin 5, Chieri, Italy
– sequence: 9
  givenname: Domenico
  surname: Cucinotta
  fullname: Cucinotta, Domenico
  organization: Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
– sequence: 10
  givenname: Roberto
  surname: Pontremoli
  fullname: Pontremoli, Roberto
  organization: Università degli Studi and IRCCS Azienda Ospedaliera Universitaria San Martino-IST, Genova, Italy
– sequence: 11
  givenname: Paola
  surname: Fioretto
  fullname: Fioretto, Paola
  organization: Department of Medicine, University of Padua, Padua, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27703024$$D View this record in MEDLINE/PubMed
BookMark eNplkU1v1DAQhi1URLctB_4AssSFHkL9lcTmttottGIRlbqIY-TYE-pV4iy2U2n_Bz8YR91eymk0o2fe-XjP0IkfPSD0jpJPjPP6yhpaFZSJ6hVaUMXLoiyFPEELQoUqSqXYKTqLcUcIEULKN-iU1TXhhIkF-nvX6zhovA3ud38wEJyFiLW3-Ga9KVZ4A4_QR3wXwDqTcHoAvJ5L434An_DY4bXTLSRn8DdnPRxyHkFHwM7j-6ndgUkR_3LpAW8Pe8DsyEP8jLdZbPl9jZfe6zzj1rvkdHKPcIFed7kCb4_xHP38cr1d3RSbH19vV8tNYbiQqQAtSluZjrUgakYE61QntQDCqdGKVBUw1kpqoOZSaNZZaw0jDFRdd0px4Ofo45PuPox_JoipGVw00PfawzjFhkpe8lJJQjP64QW6G6cw750pUTIiOZ-p90dqagewzT64QYdD8_zvDFw9ASaMMQboGuNSvnn0KWjXN5Q0s6PN7GgzO5o7Ll90PIv-z_4D1kufHA
CODEN DICAD2
CitedBy_id crossref_primary_10_1016_j_clnesp_2024_11_029
crossref_primary_10_1097_MD_0000000000032818
crossref_primary_10_1002_hsr2_1779
crossref_primary_10_3390_genes10100782
crossref_primary_10_1007_s11892_019_1263_x
crossref_primary_10_1111_dom_13508
crossref_primary_10_1016_j_jdiacomp_2023_108585
crossref_primary_10_23876_j_krcp_22_084
crossref_primary_10_1080_00325481_2018_1481714
crossref_primary_10_3389_fmed_2025_1492483
crossref_primary_10_3390_ijms19061680
crossref_primary_10_1007_s00592_019_01375_w
crossref_primary_10_1007_s40620_020_00739_8
crossref_primary_10_1016_j_jcjd_2022_04_008
crossref_primary_10_3389_fendo_2025_1503711
crossref_primary_10_1007_s44174_024_00230_z
crossref_primary_10_1016_j_jdiacomp_2021_108108
crossref_primary_10_1016_j_cca_2020_05_042
crossref_primary_10_1161_ATVBAHA_121_316615
crossref_primary_10_3390_diagnostics11050871
crossref_primary_10_1186_s12882_019_1307_0
crossref_primary_10_3390_nu13061774
crossref_primary_10_1080_00325481_2019_1643633
crossref_primary_10_1210_clinem_dgaa173
crossref_primary_10_1159_000502511
crossref_primary_10_2337_dc22_0926
crossref_primary_10_1038_s41598_024_66548_2
crossref_primary_10_1155_2024_6942156
crossref_primary_10_1016_j_jacl_2024_07_004
crossref_primary_10_1016_j_jdiacomp_2022_108357
crossref_primary_10_2147_DMSO_S387726
crossref_primary_10_1016_j_pmedr_2024_102840
crossref_primary_10_1007_s10654_019_00534_1
crossref_primary_10_1186_s13098_025_01641_8
crossref_primary_10_24985_kjss_2022_33_4_543
crossref_primary_10_3390_jcm11113224
crossref_primary_10_1007_s13410_023_01243_y
crossref_primary_10_1186_s12882_021_02429_4
crossref_primary_10_1186_s12944_023_01995_w
crossref_primary_10_1111_dom_13449
crossref_primary_10_3389_fendo_2025_1537303
crossref_primary_10_1016_j_ejphar_2021_174121
crossref_primary_10_1111_jdi_12953
crossref_primary_10_3803_EnM_2022_1604
crossref_primary_10_1080_0886022X_2019_1655451
crossref_primary_10_3390_molecules24101866
crossref_primary_10_1007_s40620_018_00561_3
crossref_primary_10_3233_THC_230811
crossref_primary_10_2337_dc18_2062
crossref_primary_10_1016_j_ejim_2023_02_019
crossref_primary_10_7759_cureus_57777
crossref_primary_10_1136_bmjopen_2023_077808
crossref_primary_10_2147_DMSO_S481578
crossref_primary_10_1186_s12944_023_01873_5
crossref_primary_10_1155_2020_3613041
crossref_primary_10_1186_s12944_024_02308_5
crossref_primary_10_1155_2018_3450141
crossref_primary_10_1136_bmjopen_2023_073536
crossref_primary_10_1016_j_ekir_2017_03_002
crossref_primary_10_2147_DMSO_S310751
crossref_primary_10_3389_fphar_2022_1052852
crossref_primary_10_1111_nep_14044
crossref_primary_10_2337_dc19_1897
crossref_primary_10_1053_j_jrn_2024_04_002
crossref_primary_10_1136_bmjopen_2023_077338
crossref_primary_10_1016_j_jpba_2022_115028
crossref_primary_10_1159_000541510
crossref_primary_10_1016_j_mmm_2023_10_008
crossref_primary_10_4239_wjd_v12_i5_524
crossref_primary_10_7717_peerj_16915
crossref_primary_10_33549_physiolres_934533
crossref_primary_10_1186_s12944_019_0970_2
crossref_primary_10_1186_s12882_022_02932_2
crossref_primary_10_1002_dmrr_3016
crossref_primary_10_1186_s12933_022_01712_4
crossref_primary_10_1016_j_ajpath_2017_10_012
crossref_primary_10_1007_s00592_021_01765_z
crossref_primary_10_1007_s12020_022_03012_z
crossref_primary_10_1371_journal_pone_0311620
crossref_primary_10_1016_j_diabres_2019_107812
crossref_primary_10_2147_DMSO_S320169
crossref_primary_10_1016_j_trsl_2023_02_004
crossref_primary_10_3389_fendo_2022_1064665
crossref_primary_10_3389_fendo_2024_1331603
crossref_primary_10_1016_j_phymed_2025_156643
crossref_primary_10_1016_j_biopha_2021_111921
crossref_primary_10_17656_jsmc_10238
crossref_primary_10_3390_jcm8050755
crossref_primary_10_15406_jdmdc_2018_05_00157
crossref_primary_10_3389_fendo_2022_888599
crossref_primary_10_3390_ijms22115808
crossref_primary_10_1186_s12877_018_0732_4
crossref_primary_10_3390_genes13071158
crossref_primary_10_1155_2018_1871530
crossref_primary_10_1007_s00467_018_4104_2
crossref_primary_10_3390_jcm10112233
crossref_primary_10_1155_2019_4831459
crossref_primary_10_1177_1479164121992524
crossref_primary_10_1016_j_biopha_2023_115400
crossref_primary_10_1016_j_diabres_2022_110079
crossref_primary_10_1186_s12944_024_02003_5
crossref_primary_10_1111_dom_14502
crossref_primary_10_3390_ijms232315023
crossref_primary_10_1007_s00592_017_0983_0
crossref_primary_10_1016_j_bbrep_2024_101839
crossref_primary_10_1007_s00592_018_1194_z
Cites_doi 10.1161/CIRCULATIONAHA.113.002529
10.1371/journal.pone.0125512
10.1093/ndt/gft506
10.1177/1479164111407783
10.1053/j.ajkd.2007.11.010
10.1016/j.jdiacomp.2013.06.002
10.2337/db05-1620
10.1016/S0140-6736(82)91513-6
10.1046/j.1523-1755.2003.00712.x
10.1038/nrendo.2009.213
10.1093/ndt/gfs290
10.2337/diabetes.54.8.2328
10.1007/s00125-009-1597-z
10.1016/j.atherosclerosis.2005.10.018
10.1111/j.1464-5491.2010.03055.x
10.1093/ndt/gfm631
10.2337/dc10-1177
10.1016/S0272-6386(12)70171-3
10.7326/0003-4819-150-9-200905050-00006
10.1016/j.atherosclerosis.2009.11.011
10.1007/s11892-015-0611-8
10.2337/diacare.26.2007.S94
10.1001/archinternmed.2009.471
10.1159/000095323
10.1111/joim.12026
10.1007/PL00002939
10.1093/ndt/gfv101
10.1074/jbc.M110650200
10.1097/MNH.0b013e32832f7002
10.1007/s40618-013-0023-z
10.1046/j.1523-1755.1999.07109.x
10.2337/dc12-0306
10.1007/s00125-010-1951-1
10.1093/ndt/gfr417
10.1038/ki.1993.129
10.1046/j.1523-1755.2001.00071.x
ContentType Journal Article
Copyright 2016 by the American Diabetes Association.
Copyright American Diabetes Association Dec 1, 2016
Copyright_xml – notice: 2016 by the American Diabetes Association.
– notice: Copyright American Diabetes Association Dec 1, 2016
CorporateAuthor the AMD-Annals Study Group
AMD-Annals Study Group
CorporateAuthor_xml – name: the AMD-Annals Study Group
– name: AMD-Annals Study Group
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
DOI 10.2337/dc16-1246
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1935-5548
EndPage 2287
ExternalDocumentID 4267499701
27703024
10_2337_dc16_1246
Genre Journal Article
Observational Study
Feature
GroupedDBID ---
-ET
..I
.XZ
08P
0R~
18M
29F
2WC
4.4
53G
5GY
5RE
5RS
5VS
6PF
8R4
8R5
AAFWJ
AAIKC
AAMNW
AAWTL
AAYEP
AAYXX
ABOCM
ABPPZ
ACGFO
ACGOD
ADBBV
AEGXH
AENEX
AERZD
AFOSN
AFRAH
AHMBA
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BENPR
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EDB
EJD
EMOBN
EX3
F5P
GX1
H13
HZ~
IAO
IEA
IHR
INH
INR
IOF
IPO
KQ8
L7B
M0K
M5~
O5R
O5S
O9-
OK1
OVD
P2P
PCD
Q2X
RHI
SV3
TDI
TEORI
TR2
TWZ
VVN
W8F
WH7
WOQ
WOW
YHG
YOC
~KM
.55
.GJ
3O-
41~
7RV
7X2
7X7
88E
88I
8AF
8AO
8C1
8F7
8FE
8FH
8FI
8FJ
8G5
AAKAS
AAQOH
AAQQT
AAYJJ
ABUWG
ADZCM
AFFNX
AFKRA
AI.
AN0
AQUVI
ATCPS
AZQEC
BCR
BCU
BEC
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BVXVI
C1A
CCPQU
CGR
CUY
CVF
DWQXO
ECM
EIF
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
IAG
ITC
J5H
K9-
M0R
M0T
M1P
M2O
M2P
M2Q
N4W
NAPCQ
NPM
PEA
PHGZT
PQQKQ
PROAC
PSQYO
S0X
SJFOW
UKHRP
VH1
WHG
X7M
ZCG
ZGI
ZXP
K9.
7X8
ID FETCH-LOGICAL-c348t-ea45d6cf2be472042f9f8a4e031ca9066e22b81ce7384a2fdddc202e977f993e3
ISSN 0149-5992
1935-5548
IngestDate Fri Jul 11 07:29:40 EDT 2025
Mon Jun 30 16:59:48 EDT 2025
Tue Apr 08 05:56:58 EDT 2025
Tue Jul 01 04:11:50 EDT 2025
Thu Apr 24 23:10:33 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License 2016 by the American Diabetes Association.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c348t-ea45d6cf2be472042f9f8a4e031ca9066e22b81ce7384a2fdddc202e977f993e3
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://care.diabetesjournals.org/content/diacare/39/12/2278.full.pdf
PMID 27703024
PQID 1845208331
PQPubID 47715
PageCount 10
ParticipantIDs proquest_miscellaneous_1835359801
proquest_journals_1845208331
pubmed_primary_27703024
crossref_citationtrail_10_2337_dc16_1246
crossref_primary_10_2337_dc16_1246
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-12-01
PublicationDateYYYYMMDD 2016-12-01
PublicationDate_xml – month: 12
  year: 2016
  text: 2016-12-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Alexandria
PublicationTitle Diabetes care
PublicationTitleAlternate Diabetes Care
PublicationYear 2016
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References Hermans (2022031222253703500_B17) 2011; 8
Adler (2022031222253703500_B26) 2003; 63
De Cosmo (2022031222253703500_B24) 2015; 30
De Cosmo (2022031222253703500_B32) 2013; 28
Jenkins (2022031222253703500_B35) 2013; 27
Asztalos (2022031222253703500_B27) 2006; 188
Hanai (2022031222253703500_B38) 2012; 27
Stadler (2022031222253703500_B39) 2015; 15
Fioretto (2022031222253703500_B3) 2010; 6
Colhoun (2022031222253703500_B1) 2001; 44
Jandeleit-Dahm (2022031222253703500_B6) 1999; 71
Nicolucci (2022031222253703500_B22) 2010; 27
Schlondorff (2022031222253703500_B13) 1993; 22
Jauregui (2022031222253703500_B33) 2009; 18
Zhou (2022031222253703500_B31) 2008; 23
Wang (2022031222253703500_B7) 2005; 54
Moorhead (2022031222253703500_B5) 1982; 2
Zager (2022031222253703500_B11) 2001; 60
Levey (2022031222253703500_B25) 2009; 150
Russo (2022031222253703500_B29) 2014
De Cosmo (2022031222253703500_B23) 2014; 29
Sun (2022031222253703500_B8) 2002; 277
Lin (2022031222253703500_B20) 2010; 53
Sacks (2022031222253703500_B21) 2014; 129
Penno (2022031222253703500_B37) 2015; 10
Molitch (2022031222253703500_B4) 2003; 26
Takemura (2022031222253703500_B12) 1993; 43
Tsun (2022031222253703500_B14) 2014
Mäkinen (2022031222253703500_B36) 2013; 273
Gröne (2022031222253703500_B10) 1996; 54
Salardi (2022031222253703500_B34) 2011; 34
Russo (2022031222253703500_B30) 2014; 37
Retnakaran (2022031222253703500_B2) 2006; 55
Han (2022031222253703500_B40) 2016
Tu (2022031222253703500_B18) 2010; 170
Russo (2022031222253703500_B28) 2010; 210
Xu (2022031222253703500_B19) 2008; 51
Morton (2022031222253703500_B15) 2012; 35
Abrass (2022031222253703500_B9) 2006; 151
Davis (2022031222253703500_B16) 2011; 54
References_xml – volume: 129
  start-page: 999
  year: 2014
  ident: 2022031222253703500_B21
  article-title: Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.113.002529
– volume: 10
  start-page: e0125512
  year: 2015
  ident: 2022031222253703500_B37
  article-title: Hypertriglyceridemia is independently associated with renal, but not retinal complications in subjects with type 2 diabetes: a cross-sectional analysis of the renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0125512
– volume: 29
  start-page: 657
  year: 2014
  ident: 2022031222253703500_B23
  article-title: Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gft506
– volume: 8
  start-page: 180
  year: 2011
  ident: 2022031222253703500_B17
  article-title: Non-invited review: prevention of microvascular diabetic complications by fenofibrate: lessons from FIELD and ACCORD
  publication-title: Diab Vasc Dis Res
  doi: 10.1177/1479164111407783
– start-page: 607924
  volume-title: Int J Endocrinol
  year: 2014
  ident: 2022031222253703500_B29
  article-title: Markers of systemic inflammation and Apo-AI containing HDL subpopulations in women with and without diabetes
– volume: 51
  start-page: 415
  year: 2008
  ident: 2022031222253703500_B19
  article-title: A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2007.11.010
– volume: 27
  start-page: 447
  year: 2013
  ident: 2022031222253703500_B35
  article-title: Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort
  publication-title: J Diabetes Complications
  doi: 10.1016/j.jdiacomp.2013.06.002
– volume: 55
  start-page: 1832
  year: 2006
  ident: 2022031222253703500_B2
  article-title: Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74
  publication-title: Diabetes
  doi: 10.2337/db05-1620
– volume: 2
  start-page: 1309
  year: 1982
  ident: 2022031222253703500_B5
  article-title: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease
  publication-title: Lancet
  doi: 10.1016/S0140-6736(82)91513-6
– volume: 63
  start-page: 225
  year: 2003
  ident: 2022031222253703500_B26
  article-title: Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64)
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2003.00712.x
– volume: 6
  start-page: 19
  year: 2010
  ident: 2022031222253703500_B3
  article-title: Residual microvascular risk in diabetes: unmet needs and future directions
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2009.213
– start-page: e0154683
  volume-title: PLoS One
  year: 2016
  ident: 2022031222253703500_B40
  article-title: Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia
– volume: 28
  start-page: 29
  year: 2013
  ident: 2022031222253703500_B32
  article-title: Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfs290
– volume: 54
  start-page: 2328
  year: 2005
  ident: 2022031222253703500_B7
  article-title: Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.8.2328
– volume: 53
  start-page: 263
  year: 2010
  ident: 2022031222253703500_B20
  article-title: Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes
  publication-title: Diabetologia
  doi: 10.1007/s00125-009-1597-z
– volume: 188
  start-page: 59
  year: 2006
  ident: 2022031222253703500_B27
  article-title: LpA-I, LpA-I:A-II HDL and CHD-risk: the Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2005.10.018
– volume: 27
  start-page: 1041
  year: 2010
  ident: 2022031222253703500_B22
  article-title: Four-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD-Annals initiative
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2010.03055.x
– volume: 23
  start-page: 927
  year: 2008
  ident: 2022031222253703500_B31
  article-title: Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfm631
– volume: 34
  start-page: 424
  year: 2011
  ident: 2022031222253703500_B34
  article-title: High rate of regression from micro-macroalbuminuria to normoalbuminuria in children and adolescents with type 1 diabetes treated or not with enalapril: the influence of HDL cholesterol
  publication-title: Diabetes Care
  doi: 10.2337/dc10-1177
– volume: 22
  start-page: 72
  year: 1993
  ident: 2022031222253703500_B13
  article-title: Cellular mechanisms of lipid injury in the glomerulus
  publication-title: Am J Kidney Dis
  doi: 10.1016/S0272-6386(12)70171-3
– volume: 150
  start-page: 604
  year: 2009
  ident: 2022031222253703500_B25
  article-title: A new equation to estimate glomerular filtration rate
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-150-9-200905050-00006
– volume: 210
  start-page: 294
  year: 2010
  ident: 2022031222253703500_B28
  article-title: Influence of menopause and cholesteryl ester transfer protein (CETP) TaqIB polymorphism on lipid profile and HDL subpopulations distribution in women with and without type 2 diabetes
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2009.11.011
– volume: 15
  start-page: 40
  year: 2015
  ident: 2022031222253703500_B39
  article-title: The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease
  publication-title: Curr Diab Rep
  doi: 10.1007/s11892-015-0611-8
– volume: 26
  start-page: S94
  year: 2003
  ident: 2022031222253703500_B4
  article-title: Diabetic nephropathy
  publication-title: Diabetes Care
  doi: 10.2337/diacare.26.2007.S94
– volume: 170
  start-page: 155
  year: 2010
  ident: 2022031222253703500_B18
  article-title: Prevention of diabetic nephropathy by tight target control in an asian population with type 2 diabetes mellitus: a 4-year prospective analysis
  publication-title: Arch Intern Med
  doi: 10.1001/archinternmed.2009.471
– volume: 151
  start-page: 106
  year: 2006
  ident: 2022031222253703500_B9
  article-title: Lipid metabolism and renal disease
  publication-title: Contrib Nephrol
  doi: 10.1159/000095323
– volume: 273
  start-page: 383
  year: 2013
  ident: 2022031222253703500_B36
  article-title: Triglyceride-cholesterol imbalance across lipoprotein subclasses predicts diabetic kidney disease and mortality in type 1 diabetes: the FinnDiane Study
  publication-title: J Intern Med
  doi: 10.1111/joim.12026
– start-page: e105787
  volume-title: PLoS One
  year: 2014
  ident: 2022031222253703500_B14
  article-title: Cellular cholesterol transport proteins in diabetic nephropathy
– volume: 44
  start-page: S46
  year: 2001
  ident: 2022031222253703500_B1
  article-title: Risk factors for renal failure: the WHO Mulitnational Study of Vascular Disease in Diabetes
  publication-title: Diabetologia
  doi: 10.1007/PL00002939
– volume: 30
  start-page: 1526
  year: 2015
  ident: 2022031222253703500_B24
  article-title: Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfv101
– volume: 277
  start-page: 18919
  year: 2002
  ident: 2022031222253703500_B8
  article-title: Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110650200
– volume: 18
  start-page: 539
  year: 2009
  ident: 2022031222253703500_B33
  article-title: Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria
  publication-title: Curr Opin Nephrol Hypertens
  doi: 10.1097/MNH.0b013e32832f7002
– volume: 37
  start-page: 261
  year: 2014
  ident: 2022031222253703500_B30
  article-title: Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease
  publication-title: J Endocrinol Invest
  doi: 10.1007/s40618-013-0023-z
– volume: 71
  start-page: S31
  year: 1999
  ident: 2022031222253703500_B6
  article-title: Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy
  publication-title: Kidney Int Suppl
  doi: 10.1046/j.1523-1755.1999.07109.x
– volume: 54
  start-page: S18
  year: 1996
  ident: 2022031222253703500_B10
  article-title: Modulation of glomerular sclerosis and interstitial fibrosis by native and modified lipoproteins
  publication-title: Kidney Int Suppl
– volume: 35
  start-page: 2201
  year: 2012
  ident: 2022031222253703500_B15
  article-title: Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study
  publication-title: Diabetes Care
  doi: 10.2337/dc12-0306
– volume: 54
  start-page: 280
  year: 2011
  ident: 2022031222253703500_B16
  article-title: Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
  publication-title: Diabetologia
  doi: 10.1007/s00125-010-1951-1
– volume: 27
  start-page: 1070
  year: 2012
  ident: 2022031222253703500_B38
  article-title: Gender differences in the association between HDL cholesterol and the progression of diabetic kidney disease in type 2 diabetic patients
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfr417
– volume: 43
  start-page: 918
  year: 1993
  ident: 2022031222253703500_B12
  article-title: Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases
  publication-title: Kidney Int
  doi: 10.1038/ki.1993.129
– volume: 60
  start-page: 2299
  year: 2001
  ident: 2022031222253703500_B11
  article-title: Renal cortical cholesterol accumulation is an integral component of the systemic stress response
  publication-title: Kidney Int
  doi: 10.1046/j.1523-1755.2001.00071.x
SSID ssj0004488
Score 2.5348403
Snippet Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains high among...
OBJECTIVE Despite the achievement of blood glucose, blood pressure, and LDL cholesterol (LDL-C) targets, the risk for diabetic kidney disease (DKD) remains...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 2278
SubjectTerms Aged
Albuminuria - blood
Albuminuria - diagnosis
Albuminuria - epidemiology
Blood Glucose - metabolism
Blood Pressure
Cholesterol, HDL - blood
Cholesterol, LDL - blood
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - epidemiology
Diabetic Nephropathies - blood
Diabetic Nephropathies - diagnosis
Diabetic Nephropathies - epidemiology
Diabetic Nephropathies - physiopathology
Dyslipidemias - blood
Dyslipidemias - complications
Dyslipidemias - diagnosis
Dyslipidemias - epidemiology
Female
Glucose
Humans
Incidence
Italy - epidemiology
Low density lipoprotein
Male
Middle Aged
Prognosis
Retrospective Studies
Risk Factors
Triglycerides - blood
Title Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative
URI https://www.ncbi.nlm.nih.gov/pubmed/27703024
https://www.proquest.com/docview/1845208331
https://www.proquest.com/docview/1835359801
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fi9NAEF7qCeKLnD-v3imj-CCUaLPZpBvfilWqZ0Whp_cWtpsNRNr0sK1g_w4f_WOd2c2mueMO1JcQkt0sZL6dzEy-mWHsWZjrOBJGBkkhdCCU6AdK4HY3OjWxSmU0s3lrk4_J-ES8P41PO53fLdbSZj17obeX5pX8j1TxGsqVsmT_QbLNQ_ECnqN88YgSxuNfyfgTmr4L1Zuihz3_qXHF3LiSy-PRhwD9bSIErYhlkZfa5iy2OUJkJjo-TKl7x2VeoXYYud81FARBjfLNMj2-UqR26iK1NX9m5bkaw8moV5dgfkcsJOWTNr296yfYCtjNz50NvhcbkC83K0MFItSOqz2iPnqrxdKFq-c_KCjQzPxSqu229AY3qrgd0YjYhXOX6z2kvsiOX-YDGmHSIocYp4TTKA7QzJFtLe1KHnk08rbO5a4J0MWPAY9sOYFc2yVcoLMFirOFRQUfkM5zedwXKm_7W9fYdTzl1B_j-HOrFj3qPlerilZ62axD9aXrmeeNnSs8GGvJTPfZrdoFgaHD023WMdUddmNSkyzusl8OVnAOVoCwAgsrcLCCGlaAsIIWrGBZgIcVOFhBDSsoK_CwAoIVEKyAg0fJK0BQAYIKHKhgB6p77OTtm-nrcVA37wh0JOQ6MErEeaILPjOCGiHxIi2kEgY_IlqlaOgazmcy1GYQSaF4kee55n1u0B8p0GY20X22Vy0rc8Agz5NU4ZdbKTMgD1_Ggod9mcokpTTvqMue-7ec6bqyPTVYmWfo4ZJsMpJNRrLpsqfN0DNXzuWyQUdeVFm921dZKEXM0V-Jwi570txGXUw_2FRllhsaE8VUEbOPYx44ETereEg8vPLOIbu52w5HbG_9fWMeocW7nj22wPsDGKGrJw
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+Triglycerides+and+HDL-C+Levels+Predict+the+Development+of+Diabetic+Kidney+Disease+in+Subjects+With+Type+2+Diabetes%3A+The+AMD+Annals+Initiative&rft.jtitle=Diabetes+care&rft.au=Russo%2C+Giuseppina+T&rft.au=De+Cosmo%2C+Salvatore&rft.au=Viazzi%2C+Francesca&rft.au=Pacilli%2C+Antonio&rft.date=2016-12-01&rft.eissn=1935-5548&rft.volume=39&rft.issue=12&rft.spage=2278&rft_id=info:doi/10.2337%2Fdc16-1246&rft_id=info%3Apmid%2F27703024&rft.externalDocID=27703024
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon